Veracyte 2024 Investor Presentation - Cancer Diagnostics

Veracyte presents its genomic diagnostic testing portfolio and strategic initiatives including the C2i Genomics acquisition. The company develops AI-powered cancer diagnostic tests including Decipher and Afirma products to transform patient care globally.